|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The Impact of Environmental Uncertainty on the Market Orientation - Performance Relationship : A Study of the Hospital Industry显示文摘 | Subhash C Loniall P S Raju | 2001 | Journal of Economic and Social Research2001，3，1： | 1 |
| 2 | Treatment options for relap- sed and refractory multiple myelomza显示文摘 | Lonial S Mitsiades CS Richardson PG | 2011 | Clin Cancer Res2011，17，6： | 1 |
| 3 | Differential effects of subjective knowledge, objective knowledge, and usage experience on decision making: An exploratory investigation 显示文摘 | RAJU P S LONIAL S C MANGOLD W G | 1995 | Journal of Consumer Psychology1995，4，2： | 1 |
| 4 | A phase I/II trial combining high-dose melphalan and Autologous transplant with-bortezomib for multiple myeloma :' a dose- and schedule-finding study显示文摘 | Lonial S Kaufman J Tighiouart M | 2010 | Clin Cancer Res2010，16，： | 1 |
| 5 | The Impact Of Quality Context And Market Orientation on Organizational Performance In a Service Environment显示文摘 | Raju P Lonial S C | 2001 | Journal of Service Research2001，，2： | 1 |
| 6 | The impact of environmental uncertainty on the market orientation performance relationship:A study of the hospital industry显示文摘 | Lonial S C Raju P S | | 0，，01： | 1 |
| 7 | Review of peripheral neuropathy in plasma cell disorders显示文摘 | Silberman J Lonial S | 2008 | Hematol Oncol2008，26，2： | 1 |
| 8 | Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: Results of a phase 1/2 study 显示文摘 | Richardson PG Chanan-Khan AA Lonial S | 2011 | Br J Haematol2011，153，6： | 1 |
| 9 | Lenalidomide,bortezomib,and dexamethasone in patients with newly diagnosed multiple myeloma:encouraging effcacy in high risk Groups with updated results of a phaseⅠ/Ⅱstudy显示文摘 | Richardson P Lonial S Jakubowiak A | 2008 | ASH Annual Meeting Abstracts2008，112，11： | 1 |
| 10 | Results of a clinical phase I dose-escalation study of cytarabinein combination with fixed-dose vinorelbine, paclitaxel, etoposideand cisplatin for the treatment of relapsed/refractory lymphoma显示文摘 | Sagar Lonial Martha Arellano Donald Hutcherson Amelia Langston Christopher Flowers L. T. Heffner Elliott Winton Mary Jo Lechowicz Edmund K. Waller | 2006 | Leukemia & Lymphoma2006，，10： | 1 |
| 11 | Clinical uses of GM - CSF, a critical ap- praisal and update显示文摘 | Arellano ML Lonial S | 2008 | Biologics2008，2，1： | 1 |
| 12 | Regulation of alloimmune responses by dendritic cell subsets显示文摘 | Lonial S Torre C David E | | 0，，10： | 1 |
| 13 | Treatment options for relapsed and refractory multiple myeloma显示文摘 | Lonial S Mitsiades CS Richardson PG | 2011 | Clin Cancer Res2011，17，6： | 1 |
| 14 | Subcutaneous versus intravenous bortezomib: efficiency practice vari- ables and patient preferences显示文摘 | Barbee MS Harvey RD Lonial S | 2013 | Ann Pharmacother2013，47，： | 1 |
| 15 | Eloquent-2 update: a phase 3, randomized, open-label study of elotuzumab in combination with lenalidomide/dexamethasone in patients with relapsed/refractory uiultiple myeloma-3-year safety and efficacy follow-up 显示文摘 | Dimopoulos MA Lonial S White D | 2015 | Blood2015，126，23： | 1 |
| 16 | Risk factors and kinetics of thromhocytopenia associated with bortezomih for relapsed, refractory multiple myeloma显示文摘 | Lonial S Waller EK Richardson PG | 2005 | Blood2005，106，： | 1 |
| 17 | Regulation of alloimmune respon- ses by dendritic cell subsets显示文摘 | Lonial S Torte C David E | 2008 | Exp Hematol2008，36，10： | 1 |
| 18 | Subcutaneous versus intra-venous bortezomib : efficiency practice variables and patient prefer-ences显示文摘 | Barbee MS Harvey RD Lonial S | 2013 | Ann Pharmacother2013，47，9： | 1 |
| 19 | Mentoring, Career Plateau Tendencies, Turnover Intentions And Implications For Narrowing Pay And Position Gaps Due To Gender-Structural Equations Modeling显示文摘 | Foster B P Lonial S Shastri T | 2011 | Journal of Applied Business Research2011，27，6： | 1 |
| 20 | Proteasome inhibnor:novel therapy for multiple myeloma显示文摘 | Kaufman JL Lonial S | 2006 | Onkologic2006，29，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员